Newsletter
Archiv der Newsletter
303, 2022
NSCLC: tepotinib, first therapy approved against the METex14 skipping alterations
Diatech Pharmacogenetics at the forefront of the selection of patients! [...]
1801, 2022
NSCLC: sotorasib first therapy approved against the KRAS G12C mutation
Non-small-cell lung cancer (NSCLC) represents 84% of all cases of [...]
411, 2020
NGS: made it Easy with Myriapod Dry!
Simple, fast, affordable: join the NGS revolution with Myriapod NGS [...]
411, 2020
EasyPGX ready KRAS together with KRAS G12C inhibitors: one more weapon in the fight against cancer!
The KRAS G12C mutation occurs in 14% of lung adenocarcinomas, 3-4% of [...]
110, 2020
Test auf DPD-Mangel – neue Leistung im EBM
Ab 01.Oktober 2020 können nun auch in Deutschland die Tests auf [...]
904, 2019
2602, 2019
EASY PGX ready FL-DNA: the first and only kit that supports the early diagnosis of CRC
EasyPGX ready FL-DNA (cod. RT029) is the first and [...]
308, 2018
The first and only kit that supports the diagnosis of colorectal cancer by avoiding unnecessary coloscopy
EasyPGX ready FL-DNA (cod. RT029) is the first and [...]